Max Healthcare Institute Limited has informed the Exchange about disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare received an appeal order from the Office of the Commissioner of Central Tax Appeal-II, Delhi on February 20, 2026, in a long-running GST case for FY 2017-18 to FY 2020-21. The original demand stood at roughly ₹2.60 crore in GST plus interest and ₹2.54 crore in penalty, totaling about ₹5.14 crore. In a positive development, the appellate authority partly allowed the company's appeal, deleting tax demand of ₹1.67 crore, penalty of ₹1.68 crore, and interest of ₹27,217. The revised outstanding demand now stands at approximately ₹85.36 lakh in GST, ₹85.36 lakh in penalty, and ₹6.89 lakh in interest, totaling about ₹1.78 crore. The company has stated there is no other material impact on its financial or operational activities and is in the process of filing a further appeal for the balance amount.
Mildly positive for shareholders as the tax demand has been reduced by roughly 65% from the original order, though a residual liability of about ₹1.78 crore remains and the company is continuing its legal challenge. The amount is small relative to Max Healthcare's overall size, so limited impact is expected on the stock price.